BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

DIGITAL THERAPEUTICS ALLIANCE, INC — Receipts Report

LD-2 disclosure · 3rd Quarter - Amendment

DIGITAL THERAPEUTICS ALLIANCE, INC

via DIGITAL THERAPEUTICS ALLIANCE, INC

3rd Quarter (July 1 - Sep 30) · 2022Posted Oct 27, 2022Filing document ↗LDA record ↗

Expenses$97Kself-filed spend

Client

Name: DIGITAL THERAPEUTICS ALLIANCE, INC
Location: Virginia · United States of America

Registrant

Firm: DIGITAL THERAPEUTICS ALLIANCE, INC
Description: Non-profit Trade Association
Location: Arlington, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
H.R.7051 - Access to Prescription Digital Therapeutics Act of 2022 S.3791 - Access to Prescription Digital Therapeutics Act of 2022
LobbyistsSUSAN ZOOK · ms SARA ELALAMY · ANDREW MOLNAR
Covered position (SUSAN ZOOK): DTA- Lobbyist
Covered position (ms SARA ELALAMY): Director of U.S Government Affairs
Covered position (ANDREW MOLNAR): Chief Executive Officer
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.